Pediatric dosing of antimicrobials: Difference between revisions
From IDWiki
(→: added clox and amp) |
(→: added amox, amox-clav, and pip-tazo) |
||
Line 55: | Line 55: | ||
|- |
|- |
||
| rowspan=4 | [[Ampicillin]] IV |
| rowspan=4 | [[Ampicillin]] IV |
||
| rowspan=2 | |
| rowspan=2 | usual dose |
||
| neonates |
| neonates |
||
| |
| |
||
| |
| 100-200 mg/kg/day split q6-8h |
||
|- |
|- |
||
| infants and children |
| infants and children |
||
| |
| |
||
| |
| 100-200 mg/kg/day split q6h (max 2 g/dose) |
||
|- |
|- |
||
| rowspan=2 | |
| rowspan=2 | meningitis |
||
| neonates |
| neonates |
||
| |
| |
||
| |
| 300 mg/kg/day split q6-8h |
||
|- |
|- |
||
| infants and children |
| infants and children |
||
| |
| |
||
| |
| 300-400 mg/kg/day split q4-6h (max 2 g/dose) |
||
|- |
|||
| rowspan=3 | [[Amoxicillin]] PO |
|||
| usual dose |
|||
| colspan=2 | |
|||
| 40-50 mg/kg/day split q8h |
|||
|- |
|||
| [[Streptococcus pneumoniae]] |
|||
| colspan=2 | |
|||
| 80-90 mg/kg/day split q8h |
|||
|- |
|||
| [[Group A Streptococcus]] pharyngitis |
|||
| colspan=2 | |
|||
| 50 mg/kg once daily x10 days (max 1 g/dose) |
|||
|- |
|||
| rowspan=2 | [[Amoxicillin-clavulanic acid]] PO |
|||
| usual dose |
|||
| colspan=2 | |
|||
| 30-50 mg/kg/day (amox component) split q8-12h (max 875 mg/dose) |
|||
|- |
|||
| [[Streptococcus pneumoniae]] |
|||
| colspan=2 | |
|||
| 80-90 mg/kg/day (amox component) split q8-12h (max 875 mg/dose) |
|||
|- |
|||
| rowspan=2 | [[Piperacillin-tazobactam]] IV |
|||
| usual dose |
|||
| colspan=2 | |
|||
| 240-300 mg/kg/day (pip component) split q6-8h |
|||
|- |
|||
| [[Pseudomonas aeruginosa]] or [[cystic fibrosis]] |
|||
| colspan=2 | |
|||
| 400 mg/kg/day split q6h |
|||
|} |
|} |
||
Revision as of 00:44, 18 November 2019
Antibiotics
Penicillins
Drug | Indication | Age | Weight | Usual dose |
---|---|---|---|---|
Penicillin G IV/IM | moderate to severe infections | 100,000 to 400,000 U/kg/day split q4-6h (max 24 MU/day) | ||
meningitis | 400,000 U/kg/day split q4h (max 24 MU/day) | |||
Penicillin VK PO | mild to moderate infections | 25-50 mg/kg/day split q8-12h | ||
rheumatic fever (treatment) | ≤ 27 kg | 300 mg PO bid x10 days | ||
> 27 kg | 600 mg PO bid x 10 days | |||
rheumatic fever (prophylaxis) | > 5 years | 300 mg PO bid | ||
asplenia (prophylaxis) | 6 months to 5 years | 150 mg PO bid | ||
> 5 years | 300 mg PO bid | |||
Cloxacillin IV | methicillin-susceptible Staphylococcus aureus | 100-200 mg/kg/day split q4-6h (max 2g/dose and 12 g/day) | ||
Cloxacillin PO | use cephalexin instead | |||
Ampicillin IV | usual dose | neonates | 100-200 mg/kg/day split q6-8h | |
infants and children | 100-200 mg/kg/day split q6h (max 2 g/dose) | |||
meningitis | neonates | 300 mg/kg/day split q6-8h | ||
infants and children | 300-400 mg/kg/day split q4-6h (max 2 g/dose) | |||
Amoxicillin PO | usual dose | 40-50 mg/kg/day split q8h | ||
Streptococcus pneumoniae | 80-90 mg/kg/day split q8h | |||
Group A Streptococcus pharyngitis | 50 mg/kg once daily x10 days (max 1 g/dose) | |||
Amoxicillin-clavulanic acid PO | usual dose | 30-50 mg/kg/day (amox component) split q8-12h (max 875 mg/dose) | ||
Streptococcus pneumoniae | 80-90 mg/kg/day (amox component) split q8-12h (max 875 mg/dose) | |||
Piperacillin-tazobactam IV | usual dose | 240-300 mg/kg/day (pip component) split q6-8h | ||
Pseudomonas aeruginosa or cystic fibrosis | 400 mg/kg/day split q6h |